Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG-Reference-Cited by-同舟云学术

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

Published:2017-06 Issue: Volume:7 Page:1-12
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Hadji Peyman,Aapro Matti S.,Body Jean-Jacques,Gnant Michael,Brandi Maria Luisa,Reginster Jean Yves,Zillikens M. Carola,Glüer Claus-C.,de Villiers Tobie,Baber Rod,Roodman G. David,Cooper Cyrus,Langdahl Bente,Palacios Santiago,Kanis John,Al-Daghri Nasser,Nogues Xavier,Eriksen Erik Fink,Kurth Andreas,Rizzoli Rene,Coleman Robert E.

Publisher

Elsevier BV

Subject

Oncology

Reference130 articles.

1. The global burden of women's cancers: a grand challenge in global health;Ginsburg;Lancet,2016

2. Bone loss and fracture risk associated with cancer therapy;Guise;Oncologist,2006

3. Concurrent gonadotropin-releasing hormone agonist administration with chemotherapy improves neoadjuvant chemotherapy responses in young premenopausal breast cancer patients;Kim;J. Breast Cancer,2015

4. Bone turnover across the menopause transition: the role of gonadal inhibins;Nicks;Ann. N.Y. Acad. Sci.,2010

5. Practical guidance for the management of aromatase inhibitor-associated bone loss;Hadji;Ann. Oncol.,2008

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer treatment-induced bone loss;The Korean Journal of Internal Medicine;2024-09-01

2. Effect of bisphosphonate and denosumab treatment on TBS in Japanese breast cancer patients with AIBL;Journal of Bone and Mineral Metabolism;2024-08-13

3. Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates;Internal and Emergency Medicine;2024-08-02

4. Medication-induced Fractures: Screening and Treatment Strategies;The American Journal of the Medical Sciences;2024-08

5. Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies;European Journal of Endocrinology;2024-07-26